DIRS.INFO The most relevant business & tech news

☆ From Amazon to The Trade Desk, experts predict these companies will be the most active acquirers of advertising businesses next year
▼ + stars: | 2022-12-27 | by ( Lara O'Reilly | ) www.businessinsider.com time to read: +7 min

There's a strong interest from acquirers in hot trends like commerce media and data consultancy. Experts predicted the companies most likely to be acquirers of advertising businesses in 2023. Many industry observers expect advertising industry M&A deal volume and value to be down next year due to volatile macroeconomic conditions. Experts across the advertising industry — from consultants, to agency executives, analysts, investors, and adtech leaders — named the companies likely to be active in the advertising M&A market in 2023 and why. Apple could make an under-the-radar adtech acquisition for its sleeping giant advertising businessIndustry insiders predict Apple has big plans for its $5 billion-and-growing advertising business next year.

☆ Are You ‘Extremely Hardcore’ or Not? How Elon Musk Is Dividing Silicon Valley’s Elite
▼ + stars: | 2022-12-24 | by ( Christopher Mims | ) www.wsj.com time to read: 1 min

Elon Musk has sometimes seemed like the person Silicon Valley would create if venture-funded engineers figured out how to build humans in a lab: the bold innovator fearlessly disrupting one industry after another with a nerdy verve. And yet these days, Silicon Valley’s investors, leaders and commentators are profoundly divided about tech’s billionaire icon, in ways that are revealing about Mr. Musk and about the state of the industry.

☆ BMO upgrades this gene-editing play, sees shares returning 65% next year
▼ + stars: | 2022-12-20 | by ( Sarah Min | ) www.cnbc.com time to read: +1 min

BMO Capital Markets sees a big year ahead for biotech company Beam Therapeutics . Analyst Kostas Biliouris upgraded shares to outperform from market perform, saying he expects updates next year on a key partnership will drive upside for the gene-editing technology company. Beam has a partnership with biotech company Verve Therapeutics , which is using Beam's base editing technology for its VERVE-101 program. "We believe these catalysts will have a direct readthrough on BEAM, each driving a ~10%+ upside (stock moves here)." Shares of Beam Therapeutics are down more than 49% in 2022, while Verve Therapeutics is off by about 51%.

☆ Nonstop partying, lavish spending, and sexual-harassment accusations: Inside the self-destruction of Pollen, the music startup once worth $800 million
▼ + stars: | 2022-12-20 | by ( Melkorka Licea | ) www.businessinsider.com time to read: +41 min

About 400 Pollen employees were camped out in Mendocino County, California, for five straight days of partying. Two former Pollen employees told Insider that they recalled the assistant telling them about Callum's inappropriate comments at the time. (The Pollen representative said Callum and Bedi didn't date at Pollen or at any other company connected to Pollen. Out of 360 events Pollen announced over the past 12 months, 39 were canceled, the Pollen representative said. (The Pollen representative said that "out of hundreds of thousands of customers, fewer than 100 people were moderated" online.)

☆ Stocks making the biggest moves in the premarket: General Mills, Steelcase, Lucid and more
▼ + stars: | 2022-12-20 | by ( Peter Schacknow | ) www.cnbc.com time to read: +2 min

Lucid (LCID) – Lucid rallied 5.% in premarket trading after the electric vehicle maker raised more than $1.5 billion in a series of stock sales. Rocket Lab (RKLB) – Rocket Lab fell 1.3% in premarket action after announcing a delay in its first rocket launch from the United States. Rocket Lab cited both poor weather conditions as well as regulatory delays stemming from the processing of documentation by NASA and the Federal Aviation Administration. As a result, Rocket Lab cut its revenue forecast for the fourth quarter. BMO expects positive announcements from Beam's partner Verve Therapeutics (VERV) to help drive the stock higher.

☆ Here are Tuesday's biggest analyst calls: Apple, Tesla, Hostess, Home Depot, Rivian, Netflix & more
▼ + stars: | 2022-12-20 | by ( Michael Bloom | ) www.cnbc.com time to read: +9 min

Here are Tuesday's biggest calls on Wall Street: Atlantic Equities names Coca-Cola as a top 2023 pick Atlantic Equities said it sees "category momentum" for shares of the beverage giant. JPMorgan reiterates Apple as overweight JPMorgan cut its price target on Apple to $190 per share from $200 due to supply chain challenges concerns. JPMorgan names Amazon as a top 2023 pick JPMorgan said Amazon is the "most diversified mega-cap across revs/profit & has numerous large growth opportunities." JPMorgan resumes DuPont as overweight JPMorgan resumed coverage of the stock and said it sees several positive catalysts ahead. JPMorgan names Bank of America a top 2023 pick JPMorgan said it likes the stock due to a "lower share of nonprime consumer loans."

☆ How a gene-editing breakthrough from a Harvard lab saved the life of a girl with leukemia
▼ + stars: | 2022-12-19 | by ( Andrew Dunn | ) www.businessinsider.com time to read: +6 min

A 13-year-old girl was the world's first patient to get a cell therapy called base editing in May. Base editing is a new gene-editing technology that could lead to cures for many diseases. Alyssa, 13, was the first-ever patient to receive a base-edited cell therapy after enrolling in a clinical trial in May. Base editing allows scientists to make ultraprecise changes to single letters of DNA in cells. Alyssa, a teenager in Leicester, England, received a base-edited cell therapy to treat her leukemia.

Dec 12 (Reuters) - News Corp (NWSA.O) named Sunday Times editor Emma Tucker the new editor of the Wall Street Journal and Dow Jones Newswires on Monday. In his new role, Murray will take on “several critical growth projects supporting News Corp,” the company said. That vision appears to align with that of the Journal's publisher and Dow Jones chief executive, Almar Latour, who is credited with leading the digital transformation of the publication, which now boasts more than 3 million digital subscribers. “Emma is a brilliant, inspiring editor, with digital nous and the highest standards of integrity,” Thomson said in a statement on Monday. “She has been a thoughtful custodian of The Sunday Times and will bring verve and virtue to Dow Jones.

☆ Croatia vs Brazil: Vatreni have 'nothing to fear' ahead of quarterfinal clash against 'terrifying' Seleçao, says head coach
▼ + stars: | 2022-12-08 | by ( Matias Grez | ) edition.cnn.com time to read: +5 min

“I try to adapt to the characteristics of the players,” Tite told reporters after the match, according to Reuters. “Sure, some love to complain when they see other people’s happiness and we Brazilians are a joyful people, so it will always bother,” Vinícius told reporters, per Reuters. Croatia has a remarkable recent record in World Cup knockout matches. Jewel Samad/AFP/Getty Images“Brazil is the favorite, let’s face it,” Dalić told reporters, per Reuters. “Brazil is the most powerful and the best national team at the World Cup.

☆ Why are there so many shock results at this World Cup?
▼ + stars: | 2022-12-03 | by ( Ben Morse | ) edition.cnn.com time to read: +9 min

We’ve seen plenty of World Cup shocks over the years, but this year’s edition has seen more than most. Lionel Hahn/Getty ImagesA World Cup like no otherThis World Cup is a first for many reasons. The World Cup’s natureGiven the nature of the World Cup – teams thrown together in a tournament setting from across the globe – fans often see clashes which they’re not accustomed to. This concoction has, over the 90 years of the World Cup, regularly led to shock results. From the US beating England in 1950 and North Korea upsetting Italy in 1966 to Senegal beating defending champion France in 2002 and Algeria – in its World Cup debut – beating West Germany in 1982, World Cup history is littered with surprises.

☆ Liverpool: After another Premier League defeat, what has gone wrong at Liverpool?
▼ + stars: | 2022-10-30 | by ( Aimee Lewis | ) edition.cnn.com time to read: +7 min

The team had won the League Cup and the FA Cup, was going toe-to-toe with Manchester City in the English Premier League, and had reached the Champions League final. Ultimately, two trophies went to Anfield instead of four, as Liverpool lost to Real Madrid in the Champions League and fell one point short in the league. For years, Liverpool has been the only team to challenge City for the league title – winning it in 2020 – yet this season Liverpool and City are worlds apart. ‘Liverpool being bullied’So, why is Liverpool struggling so badly in the league this season? “The Premier League is a really hard league to play in and is a long, difficult, sometimes physically and mentally, nine months for you.

Jerry Lee Lewis, the rock ’n’ roll trailblazer and piano virtuoso who electrified audiences with his raucous, free-wheeling performances but attracted scandal after he married his 13-year-old cousin, died Friday, his publicist said. Jerry Lee Lewis in 1957. He is a defiant, reckless, indefatigable wild man that can rock you into oblivion,” the Rock & Roll Hall of Fame said when he was inducted in 1986. Jerry Lee Lewis with Myra Gale Brown in 1962. Jerry Lee Lewis performs in 1986.

☆ 'Cabinet of Curiosities' review: Guillermo del Toro shows off his eclectic vision of horror in a Netflix anthology
▼ + stars: | 2022-10-25 | by ( Review Brian Lowry | ) edition.cnn.com time to read: +3 min

That includes a pair of original ideas from del Toro himself, “Lot 36” and “The Murmuring,” as well as two by horror author H.P. Del Toro has also handpicked the various directors, reflecting an eclectic range of projects and styles. Rupert Grint in "Dreams In The Witch House," an episode of "Guillermo del Toro's Cabinet Of Curiosities." Yet even with those disclaimers, “Cabinet of Curiosities” feels stocked with stories lacking in heft – throwing open its doors with del Toro’s buoyant enthusiasm, and too often finding its shelves looking a little bare. “Guillermo del Toro’s Cabinet of Curiosities” premieres October 25-28 on Netflix.

Investors seem to be mounting bets against some biotech and pharma names, including one that has soared in 2022. Short interest in Verve rose to 12 million shares, or 34% of its float, while 27.6 million shares of Allogene were being shorted through the end of September. Retailers Bed Bath & Beyond and Big Lots, along women's fashion company Torrid Holdings, also saw increased short interest. Short interest data is updated twice a month and reported mid-month and at the end of the month. The next release date is Oct. 25 for short interest data as of Oct. 14).

☆ Gene-editing companies are growing thanks to fast-paced science, even as biotech faces a downturn
▼ + stars: | 2022-10-12 | by ( Andrew Dunn | ) www.businessinsider.com time to read: +8 min

CRISPR companies are faring better by producing faster and more dramatic clinical results. A layoff tracker from Fierce Biotech counts at least 90 drug companies that have laid off staff in 2022. Gene-editing biotechs have avoided the brunt of the downturn because of fast clinical successIntellia Therapeutics is developing CRISPR-based gene-editing medicines that could cure diseases. Just in the past month, CRISPR Therapeutics moved into a swanky new headquarters in Boston that can house up to 1,000 people. BeamTo be sure, 2022 hasn't been smooth sailing for the CRISPR companies.

Search resuls for: "verve"

15 mentions found